Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan:146:105061.
doi: 10.1016/j.jcv.2021.105061. Epub 2021 Dec 27.

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations

Affiliations

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations

James Nyagwange et al. J Clin Virol. 2022 Jan.

Abstract

Many SARS-CoV-2 antibody detection assays have been developed but their differential performance is not well described. In this study we compared an in-house (KWTRP) ELISA which has been used extensively to estimate seroprevalence in the Kenyan population with WANTAI, an ELISA which has been approved for widespread use by the WHO. Using a wide variety of sample sets including pre-pandemic samples (negative gold standard), SARS-CoV-2 PCR positive samples (positive gold standard) and COVID-19 test samples from different periods (unknowns), we compared performance characteristics of the two assays. The overall concordance between WANTAI and KWTRP was 0.97 (95% CI, 0.95-0.98). For WANTAI and KWTRP, sensitivity was 0.95 (95% CI 0.90-0.98) and 0.93 (95% CI 0.87-0.96), respectively. Specificity for WANTAI was 0.98 (95% CI, 0.96-0.99) and 0.99 (95% CI 0.96-1.00) while KWTRP specificity was 0.99 (95% CI, 0.98-1.00) and 1.00 using pre-pandemic blood donors and pre-pandemic malaria cross-sectional survey samples respectively. Both assays show excellent characteristics to detect SARS-CoV-2 antibodies.

Keywords: IgG; Immunoassay; SARS-CoV-2; Serology; Total immunoglobulin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig 1
Fig. 1
Distribution of OD ratios of the KWTRP ELISA in 2020 and in 2021 using 467 gold standard negatives as a test population. The cut-off for positivity is shown with the dotted lines.
Fig 2
Fig. 2
ROC curves for WANTAI and KWTRP ELISAs using all gold standard positives and all gold standard negatives as a test population.
Fig 3
Fig. 3
Reproducibility of the WANTAI (A) and KWTRP (B) ELISAs by examining the raw ODs and coefficient of variation for the negative and positive controls for all the test runs done during the comparison. WANTAI negative control ODs were expected to be ≤ 0.100 and ≥1 for positive controls while the KWTRP negative control ODs were expected to be < 0.2 and >3 for positive controls. Performance of both ELISAs was as expected with little inter-assay variation.

References

    1. V'kovski P., et al. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol. 2021;19(3):155–170. - PMC - PubMed
    1. Mattiuzzo, G., et al. Establishment of the WHO International Standard and Reference Panel for anti-SARS-CoV-2 antibody 2020; Available from: https://www.who.int/publications/m/item/WHO-BS-2020.2403.
    1. Uyoga S., et al. Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors. Science. 2021;371(6524):79–82. - PMC - PubMed
    1. Etyang, A.O., et al., Seroprevalence of antibodies to SARS-CoV-2 among health care workers in Kenya. Clinical Infectious Diseases, 2021.
    1. Kagucia E.W., et al. Anti-severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibody seroprevalence among truck drivers and assistants in Kenya. Open Forum Infect. Dis. 2021;8(7) - PMC - PubMed

Publication types